KADIAN
BGP PHARMA ULC
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of KADIAN in Canada?
A shortage of KADIAN 100MG is expected: the manufacturer reported it to Health Canada as an anticipated shortage (last updated September 22, 2026), but it has not started yet.
Why is KADIAN not available?
The reason the manufacturer reported: Disruption of the manufacture of the drug.
When will KADIAN be available again?
The manufacturer's estimated resolution date is September 29, 2026. This is an estimate and can change; follow this page to get an email when the status changes.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
⚠ Extended-release and immediate-release formulations are not interchangeable — confirm the release type with your pharmacist before switching.
Other Products
ORAMORPH SR TABLETS 100MG
Extended-ReleaseROXANE LABS, DIVISION OF BOEHRINGER INGELHEIM
STATEX
KNIGHT THERAPEUTICS INC.
MS.IR
PURDUE PHARMA
MS CONTIN
PURDUE PHARMA
M-ESLON
ETHYPHARM INC
M.O.S. SULPHATE 50MG TAB
VALEANT CANADA LP / VALEANT CANADA S.E.C.
What this means
Does this mean my pharmacy is already out of stock?
No — this shortage hasn't started yet. It's an early warning that supply may become tight, based on information from the manufacturer.
What should I do?
No action is needed yet. It's worth asking your pharmacist at your next refill whether they expect any disruption for this product.
Estimated Resolution
2026-09-29
~1 day remaining (estimate)
This is the manufacturer's estimated date, not a guarantee — actual resolution may come earlier or later.
DIN
02184451
Strength
100MG
Dosage Form
CAPSULE (EXTENDED-RELEASE) CAPSULE (SUSTAINED-RELEASE)
Route
ORAL
Active Ingredient
MORPHINE SULFATE
Tier
Unrated
Last Updated
2026-09-22
Reason for Shortage
Disruption of the manufacture of the drug.
Past Reports for This Drug
KADIAN has 2 shortage/discontinuation reports on file — this is one of them.
Other Products from BGP PHARMA ULC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.